allonlinenovel Chapter 136: Expansion and Deepening of Business Cooperation
Chapter 136: Expansion and Deepening of Business Cooperation
Chapter 136: Expansion and Deepening of Business Cooperation
Mu Yang returned from the international cultural exchange arena feeling both rewarding and inspiring. However, he understood that a company's growth couldn't rely solely on cultural communication; it also required deeper development and expansion into the commercial sector. Consequently, he set his sights on fostering deeper collaboration between cultural and biotech companies, as well as seeking strategic partnerships externally, striving to carve out a broader niche in this fiercely competitive business world.
Inside the company, a meeting on deepening collaboration was underway. The creative team members of the cultural company sat together, their eyes sparkling with activity and full of novel ideas. Meanwhile, the R&D and production staff of the biotech company, with their rigorous and pragmatic approach, were focused on technology and products.
"We can design unique cultural packaging for the biotechnology company's health products, incorporating traditional Chinese medicine cultural elements, such as the Bagua diagram and the five elements' mutual generation and restraint patterns, so that the product's appearance exudes a strong cultural heritage. This will not only enhance the product's attractiveness, but also better convey its health philosophy." A creative designer from the cultural company said excitedly, waving a paintbrush in his hand and sketching some preliminary design sketches in the air.
"Well, that's a good idea. We can also plan some appealing product promotional copy, starting from the historical heritage of Chinese medicine and the precise application of modern technology, to highlight the advantages and features of the product." The copy planner also agreed, and while speaking, he quickly wrote down some key copy points in his notebook.
The R&D staff at the biotech company nodded in agreement, but also expressed their concerns: "These ideas sound great, but during implementation, we need to consider the cost and feasibility of the production process. For example, will printing complex cultural patterns increase costs? Moreover, our production process is very rigorous, and the new packaging design cannot affect the quality and shelf life of the product."
Mu Yang listened carefully to the opinions of both parties. He was well aware that this was the first challenge facing internal collaboration: how to coordinate resource allocation and ensure fair and reasonable performance evaluations. The cultural company hoped to invest more manpower and time in creative design to create more perfect works; the biotech company, on the other hand, was concerned that this would affect its normal R&D and production schedules. Furthermore, the actual benefits of cultural creativity were difficult to quantify, and therefore, the performance evaluation of its own department would be affected.
"Don't worry, everyone. We're a team, and our goal is to better market the company's products." Mu Yang stood up, resting his hands on the conference table, and looked at everyone with a determined gaze. "We can set up a joint project team to jointly develop a detailed work plan and resource allocation plan. For performance appraisals, we will comprehensively consider the contributions of all parties, not just short-term sales data, but also long-term indicators such as the improvement of brand image and the expansion of market share."
After in-depth discussions and negotiations, the two parties ultimately reached a consensus and finalized a preliminary cooperation plan. The cultural company's creative team quickly set to work, designing exquisite cultural packaging for one of the biotech company's flagship health products. The combination of antique tones and meaningful traditional patterns instantly gave the product a fresh look. Simultaneously, a series of compelling promotional copy was also created, emphasizing the product's value from every angle. The biotech company fully cooperated, adjusting some of its production processes to meet the packaging design requirements to ensure uncompromising product quality.
As internal collaboration became increasingly smooth, Mu Yang turned his attention to finding external strategic partners. By chance, he met an executive from a large internet company. At a business dinner, Mu Yang and the executive had a lively conversation, and when the possibility of collaboration between their companies was raised, both of their eyes sparkled with excitement.
"We can jointly create an online culture and health and wellness platform and integrate the advantages of both parties' resources. You have rich cultural content, whether it is the interpretation of ancient books, cultural lecture videos, or the display of artworks; we have a strong technical team and huge user traffic, and can build a convenient and efficient platform to perfectly combine cultural resources with sales channels for health products." Mu Yang passionately described the blueprint for cooperation, and the wine glass in his hand swayed slightly as he spoke.
"This idea is very attractive, and we have been looking for partners in the field of health and wellness. However, we need to have a detailed discussion on equity distribution and profit sharing. After all, this is related to the core interests of both parties." The Internet company executive frowned slightly, his expression became serious, put down the wine glass in his hand, and crossed his hands on his chest.
The ensuing negotiations were filled with intense and heated exchanges. The internet companies, leveraging their technological and market advantages, sought a larger share of the equity distribution; Mu Yang, on the other hand, argued that the cultural and biotech companies, with their unique cultural resources and product advantages, should also receive corresponding and reasonable rights. The two sides exchanged views in the conference room, each expounding on their respective positions and reasons, and the negotiations reached a stalemate.
"We understand that your technical capabilities are very strong, but our cultural content and health products are also unique advantages formed through years of accumulation and research and development. If the equity distribution is unreasonable, it will be difficult for us to reach a cooperation." Mu Yang said in a firm tone, his eyes revealing an unquestionable look, and his hands tightly grasped the documents in his hands.
"But judging from the platform's construction and operating costs, our investment is also huge. Moreover, future marketing and user acquisition will also mainly rely on our technology and channels, and we bear considerable risks." The internet company's negotiating representative retorted, beads of sweat appearing on his forehead. As he spoke, he tapped the table with his fingers to make his words more persuasive.
Mu Yang pondered for a moment and said, "Can we consider this from another angle? In addition to equity and profit sharing, we can also make more detailed divisions in resource sharing and cost sharing. For example, we can be responsible for providing high-quality cultural content and health products, and bear part of the marketing costs, in exchange for a more reasonable equity and profit distribution. At the same time, we can set some stage-by-stage goals and assessment indicators. If both parties can achieve the expectations, we can also provide additional rewards and equity distribution."
After several rounds of difficult negotiations and repeated consultations, the two sides finally found a balance on equity distribution, profit sharing, and risk sharing, and signed a cooperation agreement. At that moment, Mu Yang and the internet company executives smiled with satisfaction, shook hands tightly, and looked forward to the successful launch and operation of the online platform.
While reaching cooperation intentions with internet companies, Mu Yang also actively contacted pharmaceutical companies to seek cooperation opportunities in the field of pharmaceutical research and development. He led his team to hold several meetings and exchanges with representatives of a well-known pharmaceutical company.
"We have rich resources of traditional Chinese medicine prescriptions. These prescriptions have been tested in practice for hundreds or even thousands of years and have unique therapeutic effects. You have advanced modern pharmaceutical technology and a complete R&D system. We can establish a strategic alliance to jointly develop new drugs and combine traditional Chinese medicine wisdom with modern pharmaceutical technology. This will be a direction of cooperation with huge potential." Mu Yang sincerely introduced his ideas to the representatives of pharmaceutical companies, his eyes full of expectation and confidence, and at the same time showed some carefully compiled traditional Chinese medicine prescription materials.
Pharmaceutical company representatives expressed strong interest in these ancient prescriptions, but also raised their concerns: "Traditional Chinese medicine prescriptions have complex ingredients. How to scientifically analyze and extract the ingredients to ensure the safety and stability of the drugs is the primary issue we need to address. Moreover, during the collaboration process, we need to clarify the ownership of technology and intellectual property rights on both sides to avoid future disputes."
Mu Yang expressed his understanding and invited the company's Traditional Chinese Medicine experts and biotechnology R&D personnel to conduct in-depth technical exchanges and discussions with the pharmaceutical company's technical team. Both parties conducted detailed research and planning on issues such as formula screening, ingredient analysis, and extraction processes, and developed a preliminary R&D plan. Furthermore, with the assistance of an intellectual property lawyer, the two parties signed a rigorous technical cooperation agreement, clarifying their respective rights and obligations, as well as the ownership of intellectual property rights arising during the R&D process.
However, cultural clashes are inevitable during collaborative R&D. The diverging mindsets and workflows between the cultural and creative industries and the biotech industry already present numerous challenges for internal collaboration, and collaboration with pharmaceutical companies presents even greater cultural differences. Pharmaceutical companies' R&D processes strictly adhere to scientific norms and clinical trial standards, prioritizing data accuracy and experimental reproducibility. In contrast, teams at cultural and biotech companies are more flexible and innovative, sometimes proposing bold ideas and experiments.
"We cannot simply treat the research and development of traditional Chinese medicine prescriptions according to the traditional research and development model. We should give a certain amount of innovation space to allow our Chinese medicine experts to conduct some exploratory attempts based on traditional experience and modern theories." A Chinese medicine expert from a cultural company said somewhat excitedly, with a hint of dissatisfaction on his face. He believed that the research and development methods of pharmaceutical companies were too rigid and might limit the potential of traditional Chinese medicine prescriptions.
"But we must ensure the scientific nature and safety of the research and development process. If we try it at random, once problems arise, the consequences will be disastrous." The head of research and development at the pharmaceutical company responded seriously, his eyes revealing his adherence to scientific rigor, his hands folded across his chest, his tone unquestionable.
Mu Yang recognized that this was a clash of different corporate cultures during the strategic alliance process, and that a way to integrate them was essential. He organized several cross-team communication meetings to allow members from both sides to gain a deeper understanding of each other's working methods and cultural backgrounds, encouraging mutual learning and reference. He also established a dedicated coordination team to mediate disagreements and ensure smooth progress during the R&D process.
With the deepening of internal collaboration and the addition of external strategic partners, the company has gradually embarked on a path of diversified development. Mu Yang is filled with a sense of opportunity and challenge. He understands that every collaboration is a risk, but also an opportunity for growth. Looking at the busy and energetic team at the company and the corporate development blueprint hanging in the conference room, he is filled with optimism and confidence in the company's overall development prospects. He believes that as long as they can continuously expand and deepen business collaborations and fully leverage their strengths in all aspects, they will be able to gain a foothold in this rapidly changing business world, achieve the company's long-term development goals, and seamlessly integrate culture with technology, health, and other fields to create greater commercial and social value.